while ATP availability also influences inflammasome activation 5,6
Although a zinc chloride-based formulation of taspoglutide, facilitating subcutaneous precipitation, showed promising results, phase 3 trials were completed, but a submission for approval was discontinued, due to a number of cases of anaphylactic shock (49, 50)
The available pen doses are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg
The shedding correlates more closely with the speed and magnitude of weight loss than with semaglutide exposure itself
Not everyone with OA will benefit from this drug class, and the early promise of the mechanistic data hasnt fully translated into consistent clinical trial results